Pharmacology - Innovators

Asst. Prof. Vasundhara Sawant: Assistant Professor and Head, Department of Pharmaceutical Chemistry, Smt. Kashibai Navale College of Pharmacy, Kondhwa Bk Pune, India

Mrs. Vasundhara N. Sawant is an accomplished Assistant Professor and Head of the Department of Pharmaceutical Chemistry at S.T.E.S.’s Smt. Kashibai Navale College of Pharmacy, Pune. With over nine years of experience in pharmaceutical education and research, she has developed expertise in medicinal chemistry, organic synthesis, and computational drug design. She is deeply committed to advancing pharmaceutical sciences through eco-friendly synthetic methods and novel drug discovery approaches, particularly focusing on diabetes, cancer, and metabolic disorders. In addition to her academic roles, Mrs. Sawant actively mentors postgraduate students and contributes to scientific literature, fostering innovation in pharmaceutical chemistry.

Online Profiles

ORCID Profile

Education

Currently pursuing her Ph.D. at Savitribai Phule Pune University (2020–2025), Mrs. Sawant has demonstrated academic excellence throughout her education. She obtained her Master of Pharmacy degree in 2016 from the Government College of Pharmacy, Karad, affiliated with Shivaji University, Kolhapur, specializing in pharmaceutical chemistry. She completed her Bachelor of Pharmacy degree in 2014 from KES Rajarambapu College of Pharmacy, Kasegaon, also under Shivaji University. Additionally, she qualified in competitive exams such as GPAT and NIPER in 2014, reflecting her strong academic foundation and commitment to research.

Research Focus

Mrs. Sawant’s research encompasses a broad spectrum of pharmaceutical chemistry disciplines, with a particular emphasis on heterocyclic synthesis, green and sustainable catalysis, and eco-friendly chemical reactions. Her work extends to diabetes and metabolic drug discovery, leveraging computational and quantum drug development tools including in-silico drug design and molecular modeling. She also investigates anticancer and antifungal agents derived from synthetic and phytochemical sources, combining biological evaluation with advanced chromatographic and analytical techniques to validate drug efficacy and safety.

Experience

With nine years of progressive academic experience, Mrs. Sawant has cultivated a comprehensive skill set in teaching, research, and academic administration. Since December 2017, she has been an Assistant Professor at Smt. Kashibai Navale College of Pharmacy, where she also heads the Department of Pharmaceutical Chemistry. Prior to this, she served as faculty at Genba Sopanrao Moze College of Pharmacy and PDEA’s Shankarrao Ursal College of Pharmaceutical Sciences and Research Centre, contributing to curriculum development and student mentoring. Her teaching portfolio includes undergraduate and postgraduate courses in organic, medicinal, and inorganic pharmaceutical chemistry, highlighting her versatility and expertise.

Research Timeline & Activities

Since embarking on her Ph.D. journey in 2020, Mrs. Sawant has been actively engaged in multiple research projects focused on environmentally benign synthesis of heterocyclic compounds and computational drug design. She has authored numerous peer-reviewed articles in indexed journals and presented research at both national and international scientific forums. Her research activities also involve supervising postgraduate students, developing novel methodologies for drug stability and assay analysis, and securing intellectual property through patents. Her scholarly contributions include authoring book chapters and collaborating with interdisciplinary teams to promote translational pharmaceutical research.

Awards & Honors

Mrs. Sawant has received several prestigious awards recognizing her academic and research excellence. Notably, she was awarded a Gold Medal by Shivaji University for outstanding performance in her Bachelor of Pharmacy program. She also received the IDMA J B Mody Best Student Award from the Indian Drug Manufacturers Association, honoring her scholastic achievements. Additionally, the Indian Pharmaceutical Association recognized her for excellent academic performance during her undergraduate studies. Her memberships and registrations, including her life membership in the Association of Pharmaceutical Teachers of India and her status as a registered pharmacist, further attest to her professional standing.

Top Noted Publication

Among her significant publications, the comprehensive review titled “Environmentally benign synthesis of heterocyclic compounds using various catalytic approaches,” published in Biointerface Research in Applied Chemistry (2025, Impact Factor: 2.54), stands out as a seminal work. This paper synthesizes current advancements in sustainable catalysis and heterocyclic chemistry, offering insights into eco-friendly synthetic methodologies. The article is indexed in both Scopus and Web of Science, reflecting its impact and recognition within the pharmaceutical chemistry research community. This publication exemplifies Mrs. Sawant’s commitment to advancing green chemistry in drug development.

Environmentally benign synthesis of heterocyclic compounds using various catalytic approaches: A comprehensive review
Biointerface Research in Applied Chemistry, October 2025
Role: Writing – Review & Editing
Summary: A detailed review on sustainable and eco-friendly catalytic methods for heterocyclic synthesis.
Comprehensive Review and Perspective on Fructose 1,6-Bisphosphatase inhibitors for the management of Type 2 Diabetes Mellitus
Russian Journal of Bioorganic Chemistry, April 2025
Co-author: Sanjay D. Sawant
Focus: Exploration of novel inhibitors targeting diabetes management.
Thin-layer chromatography coupled with mass spectrometry for identification of degradants for phycocyanin
Journal of Planar Chromatography – Modern TLC, 2024
DOI: 10.1007/s00764-024-00317-9
Co-authors: Minal Ghante, Neha Bhaware, Rohan Thosar, Supriya Jagtap, Vidhya Bhusari
Highlights: Advanced analytical techniques for drug degradation study.
3D Prediction Model for Design of Novel Antidiabetic Agents
Avishkar Conference, November 2024
Co-author: Sanjay D. Sawant
Description: Presentation on computational modeling for designing new antidiabetic drugs.
Computational investigation of phytochemicals for treatment of Diabetes mellitus and obesity
International Conference on Recent Advances on Green Catalysis and Drug Discovery, August 2024
Co-author: Sanjay D. Sawant
Topic: Use of computational tools to assess phytochemicals’ therapeutic potential.

Strengths for Best Innovator Award

Pioneering Research in Green and Sustainable Chemistry
Mrs. Vasundhara N. Sawant has established herself as a pioneer in developing environmentally benign synthetic methodologies. Her innovative research on heterocyclic compound synthesis using green catalytic approaches not only contributes to cutting-edge pharmaceutical chemistry but also addresses global concerns of sustainability and environmental preservation. By reducing reliance on hazardous reagents and minimizing waste generation, her work promotes safer, cost-effective, and scalable drug manufacturing processes that are aligned with modern green chemistry principles.

Interdisciplinary Approach to Drug Discovery
Mrs. Sawant exemplifies innovation through her seamless integration of traditional medicinal chemistry with advanced computational and quantum techniques. Utilizing molecular modeling, in-silico drug design, and quantum drug development tools, she effectively accelerates the drug discovery pipeline for complex diseases such as diabetes, cancer, and metabolic disorders. This cross-disciplinary expertise allows her to generate novel drug candidates with higher precision, reduced development time, and improved therapeutic efficacy, positioning her work at the forefront of modern pharmaceutical innovation.

Translation of Research into Practical Applications
Beyond theoretical contributions, Mrs. Sawant actively bridges the gap between research and real-world impact. She has developed novel analytical methods, including stability-indicating assays and chromatographic techniques, to ensure drug safety and quality. Her patent achievements further reflect her commitment to translating innovative ideas into tangible intellectual property, with potential commercial and clinical applications. This practical orientation demonstrates her ability to foster innovation that benefits both industry and society.

Strong Academic Leadership and Mentorship
As the Head of the Department of Pharmaceutical Chemistry and a recognized guide for postgraduate students, Mrs. Sawant nurtures a culture of research excellence and innovation within her academic community. She mentors young researchers, encouraging original thinking, critical analysis, and problem-solving skills. Her leadership extends to curriculum development and research collaborations, creating an environment conducive to scientific breakthroughs and the cultivation of future innovators in pharmaceutical sciences.

Recognition and Scholarly Impact
Mrs. Sawant’s innovative contributions have been recognized by prestigious awards such as the IDMA J B Mody Best Student Award and a Gold Medal from Shivaji University. Her research has been published extensively in high-impact, peer-reviewed journals indexed in Scopus and Web of Science, signifying her influence and thought leadership in pharmaceutical chemistry. Additionally, her active participation in national and international conferences highlights her role as a knowledge disseminator and innovator, fostering collaborations and driving the field forward.

Maitreyi Zaveri, Pharmacology, Best Innovator Award

Posted on 30/09/2025 by scizentox scizentoxLeave a Comment

Prof. Dr. Maitreyi Zaveri: Professor and Head of Pharmacognosy and Pharma regulatory Affairs Department at K.B. Institute of Pharmaceutical Education and Research (KBIPER), India

Dr. Maitreyi Zaveri, MPharm, PhD, is a distinguished academic and researcher with over 30 years of experience in the pharmaceutical sciences. Currently serving as the Head and Professor of the Department of Pharmacognosy & Pharmaceutical Regulatory Affairs at K. B. Institute of Pharmaceutical Education & Research (KBIPER), Gandhinagar, Gujarat, she has made significant contributions in the areas of herbal drug development, regulatory science, and phytopharmacology. Her deep-rooted knowledge of regulatory frameworks, coupled with her practical experience in industry and academia, has made her a leading voice in the Indian pharmaceutical education and research ecosystem.

Online Profiles

Scopus Profile

Dr. Maitreyi Zaveri has published 36 Scopus-indexed documents, accumulating 323 citations from 295 documents, reflecting a solid and consistent academic contribution in the field of pharmacognosy and regulatory affairs. She holds an h-index of 9, indicating the quality and impact of her work across peer-reviewed journals. Her most impactful research includes the granted patent titled “A Novel Herbal Formula for Treatment and Management of Breast Cancer Using Ethnomedicinal Plants” (Patent No. 523952, granted in March 2024), which showcases her expertise in herbal drug development and the therapeutic application of indigenous medicinal plants. She is also recognized for her cross-disciplinary publications involving phytochemistry, pharmacology, and global regulatory practices

Education

Dr. Zaveri completed her Bachelor of Pharmacy in 1991, Master of Pharmacy (Pharmacognosy) in 1993, and PhD in Pharmacognosy in 2005, all from L. M. College of Pharmacy, Gujarat University, Ahmedabad. Her MPharm research was guided by Dr. M. G. Chauhan, while her doctoral research was supervised by Dr. Sunita Jain, focusing on pharmacognostical and pharmacological aspects of medicinal plants. Her strong foundational education has underpinned a career focused on integrating traditional herbal knowledge with modern regulatory and scientific frameworks.

Research Focus

Dr. Zaveri’s primary research interests lie in herbal formulation development, phytochemical screening, phytopharmacology, and analytical method development using in-vitro, ex-vivo, and in-vivo models. Her work extends into the domain of pharmaceutical regulatory science, with expertise in dossier compilation and submission (NDA, ANDA, INDA), compliance with GMP, GLP, and global regulatory standards. She also actively works on ethnomedicinal plants, aiming to scientifically validate traditional knowledge and translate it into therapeutic products with commercial potential.

Experience

Dr. Zaveri began her career in the pharmaceutical industry as a Production Executive at Torrent Pharmaceuticals Ltd. (1993–1998), followed by academic roles at L. M. College of Pharmacy and Ramanbhai Patel College of Pharmacy. Since 2007, she has been the Professor and Head at KBIPER, where she leads both the Pharmacognosy and Regulatory Affairs departments. She has played a pivotal role in developing the institute’s research ecosystem and has contributed significantly to teaching, curriculum development, training, and regulatory certifications for both students and faculty members.

Research Timeline & Activities

Over her academic career, Dr. Zaveri has successfully guided 10 PhD scholars (with 2 currently enrolled) and more than 100 MPharm students, nurturing the next generation of researchers. She has completed 22 funded research projects, amounting to over ₹42 lakhs, supported by funding agencies like GUJCOST, DST, AICTE, and BIRAC. Her research outputs include 158 peer-reviewed publications, 189 conference presentations, and 3 patents (1 granted and published, 1 granted, 1 under review). She has also authored multiple textbooks and contributed chapters to internationally published books.

Awards & Honors

Dr. Zaveri has received multiple national and international awards for her academic and research excellence. Notable recognitions include the Women Researcher Award (2020), and First Prizes at major conferences such as NiPICON-2018, ISPRA Symposium, and the Indo-American Pharmaceutical Regulatory Symposium. She has also been awarded by GUJCOST for her state-level paper presentations in 2004 and 2008. These accolades reflect her continued excellence in both educational leadership and scientific innovation.

Top Noted Publication

Among Dr. Zaveri’s significant scientific contributions, one of the most prominent is the granted Indian patent (No. 523952) titled “A Novel Herbal Formula for Treatment and Management of Breast Cancer Using Ethnomedicinal Plants”, awarded in March 2024. This innovation demonstrates her commitment to bridging traditional herbal knowledge with modern pharmaceutical applications. In addition to patents, her published work—cited over 1,187 times with an h-index of 16—highlights her impact on the scientific community.

Book Chapter

Zaveri, Maitreyi, and Bhavita Dhru.
“Regulatory Provisions for Food Supplements in India.”
In Nutraceuticals: Global Regulatory Status and Challenges, Volume 1, CRC Press, Taylor & Francis Group, 2025.
(Covers Indian regulations related to nutraceuticals and food supplements.)

Recent Journal Articles

Zaveri, Maitreyi, et al.
“Mechanistic insights into the anti-ulcerative effects of Avipattikar churna: a network pharmacology and experimental approach.”
Proceedings of the Indian National Science Academy, 2025.
(Integrates network pharmacology with experimental validation of Ayurvedic formulation.)
Zaveri, Maitreyi, et al.
“Novel gastroretentive formulation of an Ayurvedic churna for peptic ulcers: Optimization and evaluation.”
Journal of Research in Pharmacy, 2024.
(Focuses on the development of a gastroretentive drug delivery system for Ayurvedic medicine.)

Strength for the Best Innovator Award

1. Innovative Research in Ethnomedicinal Drug Development

Dr. Zaveri has consistently focused on blending traditional ethnomedicinal knowledge with modern pharmaceutical techniques. Her innovation is evidenced by multiple patents, including a granted Indian patent for a novel herbal formula to treat breast cancer. This reflects a strong commitment to converting indigenous knowledge into validated, therapeutic interventions—an innovation highly relevant to modern drug discovery.

2. Pioneering Work in Herbal Formulations and Phytopharmacology

Her work in developing novel herbal drug delivery systems, such as gastroretentive formulations for Ayurvedic churnas, showcases her ability to adapt ancient remedies for modern needs using scientific methods like network pharmacology and experimental validation. This positions her as a key innovator in making herbal medicines more effective and accessible.

3. Leadership in Pharmaceutical Regulatory Affairs

Dr. Zaveri is not only an academician but a national leader in pharmaceutical regulatory science. She has led and organized numerous certificate courses, conferences, and faculty development programs under the banner of ISPRA (Indian Society of Pharmaceutical Regulatory Affairs). Her contribution to developing regulatory literacy in India is innovative in bridging academia, industry, and policy.

4. Successful Translation of Research into Patents and Products

With three patents (two granted and one in process) and over 22 funded research projects, Dr. Zaveri has a proven track record of translational research. Her ability to move from lab-scale innovation to intellectual property reflects a deep understanding of applied pharmaceutical research, making her work valuable beyond academia.

5. Mentorship-Driven Innovation Culture

As a guide to over 100 MPharm students and 10 PhD scholars, Dr. Zaveri has created an environment that fosters young innovators. Many of her projects are collaborative and interdisciplinary, emphasizing innovation through team-based learning and real-world problem-solving, especially in herbal and regulatory science.

Avinash Tekade, Pharmacology, Pharmaceutical Innovation Award

Posted on 30/09/2025 by scizentox scizentoxLeave a Comment

Prof. Dr. Avinash Tekade: Professor of Pharmaceutics & Dean, Research & Development at Marathwada Mitra Mandal’s College of Pharmacy, Thergaon, Pune

Dr. Avinash R. Tekade is a distinguished pharmaceutical scientist and educator with more than 27 years of rich experience in teaching, research, and academic leadership. He currently holds the positions of Professor and Head of the Department of Pharmaceutics as well as Dean of Research and Development at Marathwada Mitra Mandal’s College of Pharmacy in Pune. Dr. Tekade’s expertise lies in pharmaceutical nanotechnology, novel drug delivery systems, and translational research aimed at improving therapeutic efficacy and patient compliance. His dedication to research and education has established him as a respected figure in the pharmaceutical sciences community.

Online Profiles

Scopus Profile

Dr. Avinash R. Tekade is a renowned pharmaceutical scientist based at Marathwada Mitra Mandal’s College of Pharmacy, Pune, India. With a Scopus Author ID of 21834750200 and an ORCID identifier 0000-0001-8564-1859, he has made significant contributions to the field of pharmaceutics, reflected by over 1,683 citations across 44 published documents. His impactful research has been cited by more than 1,479 scholarly works, establishing his academic footprint with an h-index of 21. Dr. Tekade’s work primarily focuses on novel drug delivery systems and pharmaceutical nanotechnology, making him a leading figure in advancing therapeutic sciences.

Education

Dr. Tekade completed his Bachelor of Pharmacy (B.Pharm) with first-class honors from RTM Nagpur University in 1995, followed by a Master of Pharmacy (M.Pharm) specializing in Pharmaceutics from BITS Pilani in 1999. He further enhanced his research skills by obtaining a Ph.D. in Pharmaceutical Sciences from KBC North Maharashtra University in 2010. Throughout his academic journey, he focused on the development of advanced drug delivery systems, which laid the foundation for his subsequent research career and innovations in pharmaceutical nanotechnology.

Research Focus

His primary research interests include the design and development of novel drug delivery systems such as lipid nanoparticles, solid dispersions, and targeted nanocarriers. Dr. Tekade is especially focused on overcoming challenges related to poor drug solubility and bioavailability. Recently, his work has expanded to exploring nasal-to-brain delivery routes, aiming to improve treatments for central nervous system disorders by bypassing the blood-brain barrier. He also investigates transdermal drug delivery systems, contributing to safer and more effective patient-centric therapeutic options.

Experience

Dr. Tekade has held academic positions ranging from lecturer to professor and head of department, spanning nearly three decades. He has taught undergraduate, postgraduate, and doctoral students, fostering the next generation of pharmaceutical scientists. He has supervised over 85 M.Pharm theses and 7 Ph.D. candidates, many of whom have gone on to contribute to academia and industry. Beyond teaching, he has managed multiple funded research projects from national agencies like the Department of Science & Technology (DST) and the Rajiv Gandhi Science & Technology Commission (RGSTC), cumulatively worth over Rs. 90 lakhs.

Research Timeline & Activities

Dr. Tekade began publishing research articles in 2005 and has since authored more than 60 peer-reviewed journal papers, book chapters, and conference proceedings. His pioneering studies on nanoparticulate drug delivery, dry powder inhalations, and solid dispersions have been well recognized in the scientific community. He has filed multiple patents related to pharmaceutical formulations and delivery technologies. Active participation in international conferences and workshops reflects his commitment to continuous learning and sharing knowledge globally.

Awards & Honors

Dr. Tekade’s contributions have been acknowledged through several prestigious awards. Among them, the Prof. Man Mohan Sharma Science & Technology Award presented by the Marathi Vidnyan Parishad, Mumbai, in 2019 stands out for recognizing his innovative work in pharmaceutical sciences. He has received grants and fellowships from leading science bodies and has been invited as a keynote speaker at various international symposia, showcasing his role as a thought leader in drug delivery research.

Top Noted Publication

One of Dr. Tekade’s most influential works is his chapter titled “Nanoparticles for direct nose-to-brain drug delivery: Implications of targeting approaches,” published in the book Direct Nose-to-Brain Drug Delivery by Academic Press in 2021. This publication is highly cited for advancing the understanding of how nanoparticulate carriers can bypass the blood-brain barrier to deliver drugs effectively for neurological conditions, thus opening new avenues in CNS therapeutics and nanomedicine.

Design and assessment of in-situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia
Journal of Research in Pharmacy, 2025 (Open Access)
This innovative study explores the development of a nasal gel formulation using nanostructured cubosomes aimed at enhancing targeted drug delivery for schizophrenia, highlighting novel approaches in neurotherapeutics.
RP-HPLC Method Development and Validation for the Determination of Remdesivir in IV Formulation
Indian Drugs, 2025
This article presents a validated reverse-phase high-performance liquid chromatography (RP-HPLC) method for accurately quantifying remdesivir in intravenous formulations, contributing essential analytical tools for pharmaceutical quality control.
Development and Evaluation of Remdesivir Dry Powder Inhalation Formulation by Spray Drying Technique
Journal of Applied Pharmaceutical Science, 2025 (Open Access)
This research focuses on the formulation of remdesivir as a dry powder for inhalation via spray drying, offering promising alternatives for pulmonary delivery of antiviral drugs.
Core-Shell Nanoparticles for Pulmonary Drug Delivery
A comprehensive review discussing the design, advantages, and therapeutic applications of core-shell nanoparticles, emphasizing their potential for targeted and controlled pulmonary drug delivery.

Strengths for Pharmaceutical Innovation Award

Pioneering Research in Nanotechnology-Based Drug Delivery:
Dr. Tekade has extensively contributed to the development of innovative drug delivery systems, including nanoparticles, nanostructured cubosomes, and dry powder inhalations. His work on nasal-to-brain delivery and pulmonary drug formulations represents a cutting-edge approach to overcoming conventional therapeutic limitations, such as poor bioavailability and blood-brain barrier penetration.
Significant Academic and Research Leadership:
With over 27 years of academic experience, Dr. Tekade has demonstrated strong leadership as Professor, Head of Pharmaceutics, and Dean of Research & Development. His role in mentoring over 85 M.Pharm and 7 Ph.D. candidates highlights his dedication to nurturing future innovators in pharmaceutical sciences.
High Impact Research and Recognition:
Boasting an h-index of 21 and more than 1,683 citations, Dr. Tekade’s publications are widely acknowledged and influential in the field. His chapter on nose-to-brain drug delivery is recognized as a seminal work, shaping current understanding and future research directions in CNS drug targeting.
Successful Management of Funded Research Projects:
Dr. Tekade has secured and managed multiple competitive research grants totaling over Rs. 90 lakhs from reputed agencies such as DST and RGSTC. These projects underscore his capability to translate innovative ideas into funded, impactful research initiatives.
Award-Winning Contributions and Global Engagement:
Recipient of the prestigious Prof. Man Mohan Sharma Science & Technology Award, Dr. Tekade is recognized for his innovation and scientific excellence. His active participation as a keynote speaker in international forums reflects his status as a global thought leader driving pharmaceutical innovation.

Prerona Boruah, Pharmacology, Innovative Researcher Award

Posted on 11/09/202511/09/2025 by scizentox scizentoxLeave a Comment

Dr. Prerona Boruah: Research Director at Association of Ayushinventors, India

Title/Designation: Dr
Name: Prerona Boruah
Current Role/Designation: Research Director
Organization/Institution: Association of Ayushinventors, India
Subject Track: Pharmacology
Key Areas of Expertise: Cancer Immunology
Award Category: Innovative Researcher Award

Dr. Prerona Boruah is a highly skilled immunologist with a Ph.D. in Immunology and more than seven years of experience spanning academic research, biotech industry projects, and translational oncology initiatives. Her expertise covers the full spectrum from molecular assays and preclinical model development to regulatory submissions and stakeholder coordination. Having worked across India, China, and now the Netherlands, she has developed a versatile scientific and managerial profile, bringing together strong laboratory experience, protocol and SOP development, clinical study coordination, and leadership in multidisciplinary teams. She is now pivoting into translational oncology, where she is motivated to apply her immunology background to biomarker discovery, liquid biopsy studies, and colorectal cancer research.

Online Profiles

Google Scholar Profile

Publication Metrics

Her publications have collectively earned 273 citations, with an h-index of 6 and an i10-index of 5, reflecting her impact in immunology and oncology research through both original articles and reviews.

Education

She earned her Ph.D. in Immunology from the Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, in 2019. Her doctoral research explored the role of Interleukin-34 (IL-34) in Japanese Encephalitis Virus infection, using both neuronal cell culture and knockout mouse models. Before this, she obtained her Master of Science in Biotechnology from North Eastern Hill University, India, in 2015, where she built her foundation in molecular biology and immunological techniques. Her academic journey began with a Bachelor of Science in Biotechnology from St. Anthony’s College, Shillong, India, in 2013, which inspired her transition into advanced biomedical sciences and translational medicine.

Research Focus

Dr. Boruah’s research interests bridge fundamental immunology and applied oncology. She is particularly focused on translating discoveries from cytokine biology and immune cell signaling into practical cancer therapeutics and diagnostics. Her work covers biomarker discovery, preclinical disease models, cancer immunology, antibody therapeutics, and molecular assays. With increasing emphasis on clinical relevance, she is building expertise in coordinating liquid biopsy and ctDNA studies for colorectal cancer, aiming to translate biomarker findings into meaningful clinical impact. She is equally engaged in regulatory science, documentation, and SOP development, which enables her to integrate scientific innovation with compliance and implementation in clinical and industrial settings.

Experience

Currently serving as Research Director at the Association Ayush Inventors, Dr. Boruah leads the coordination of non-clinical testing projects, standardizes SOPs, and ensures data traceability for intellectual property and regulatory purposes. From 2022 to 2024, she was Principal Investigator at Padmashree Dr. D.Y. Patil Deemed to be University, where she directed therapeutic studies, authored protocols, won grants, and supervised students while driving immunology and oncology research. Earlier, she worked at Zhejiang Wolwo Biopharmaceuticals in Shanghai as a Project Lead and Drug Regulation Specialist, designing preclinical study protocols, preparing FDA/NMPA/CDSCO submissions, and contributing to GLP/GMP and QMS systems. Her scientific career began as a Ph.D. researcher at the Shanghai Veterinary Research Institute, where she investigated viral immunopathogenesis and authored several SCI publications.

Research Timeline & Activities

Between 2016 and 2019, Dr. Boruah pursued her Ph.D. in China, focusing on cytokine IL-34 and its role in viral pathogenesis. This phase gave her significant exposure to molecular and cellular techniques as well as animal models. From 2019 to 2022, she entered the biotech sector in Shanghai, where she led translational projects and contributed to high-stakes regulatory submissions. Returning to India in 2022, she transitioned into academic leadership as a Principal Investigator, securing grants and mentoring a new generation of students. Since 2024, she has been serving as Research Director in a global role with Association Ayush Inventors, coordinating multidisciplinary research, consolidating outputs into publications and patents, and driving translational innovation at the interface of academia, biotech, and clinical application.

Awards & Honors

Dr. Boruah’s contributions have been recognized through successful external research grants, her appointment to leadership positions in academic and research organizations, and her role as co-inventor on two patent applications filed in India in 2024 and 2025. These patents cover an antidiabetic extract and a phytomolecular anti-cancer extract formulation, reflecting her drive to translate laboratory discoveries into practical therapeutic solutions. She has also been acknowledged for her contributions to manuscript authoring, regulatory submissions, and her ability to bridge diverse research environments across multiple countries.

Top Noted Publication

Among her body of publications, one particularly notable work is her review article “Interleukin-34 in Disease Progressions: A Comprehensive Review” published in Critical Reviews in Immunology (2023). This paper synthesizes the current understanding of IL-34 in various diseases, including cancer and infectious diseases, and has become a reference point for researchers working on cytokine biology. In addition, her recent works in 2024 and 2025 on cancer therapeutics and natural product-based interventions demonstrate her expanding contributions to translational oncology and biomarker research.

Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO₂NPs) and Their Jeopardy to Human Population
S. Shabbir, M.F.A. Kulyar, Z.A. Bhutta, P. Boruah, M. Asif
Bionanoscience 11 (2), 621–632, 2021
Citations: 126
The emerged genotype I of Japanese encephalitis virus shows an infectivity similar to genotype III in Culex pipiens mosquitoes from China
M. Hameed, K. Liu, M.N. Anwar, A. Wahaab, A. Safdar, D. Di, P. Boruah, J. Xu, …
PLoS Neglected Tropical Diseases 13 (9), e0007716, 2019
Citations: 36
Genome-wide transcriptome profiling uncovers differential miRNAs and lncRNAs in ovaries of Hu sheep at different developmental stages
S. Shabbir, P. Boruah, L. Xie, M.F.A. Kulyar, M. Nawaz, S. Yousuf, T. Liu, …
Scientific Reports 11 (1), 5865, 2021
Citations: 32
Cotton fabric loaded with ZnO nanoflowers as a photocatalytic reactor with promising antibacterial activity against pathogenic E. coli
A. Ashar, Z.A. Bhutta, M. Shoaib, N.K. Alharbi, M. Fakhar-e-Alam, M. Atif, …
Arabian Journal of Chemistry 16 (9), 105084, 2023
Citations: 30
Evaluation of hematological, antioxidant enzymes and oxidative stress parameters in buffaloes infected with babesiosis
Z.A. Bhutta, M.F.A. Kulyar, I.S. Jahanzaib, S. Shabbir, P. Boruah, A. Bello
Continental Vet J 2 (1), 29–34, 2022
Citations: 22

Strengths for the Innovative Researcher Award

1. Translational and Multidisciplinary Expertise

Dr. Boruah seamlessly integrates fundamental immunology with applied oncology, demonstrating a unique ability to translate laboratory discoveries into clinically relevant outcomes. Her work spans cytokine biology, immune cell signaling, biomarker discovery, and liquid biopsy studies, reflecting a comprehensive understanding of both basic science and translational research. This multidisciplinary approach enables her to bridge the gap between preclinical models and therapeutic applications, making her contributions highly innovative and impactful.

2. Global Research Experience and Leadership

Having worked across India, China, and the Netherlands, Dr. Boruah brings a versatile international perspective to research coordination and scientific problem-solving. She has led multidisciplinary teams in academia and industry, supervising students, managing projects, standardizing SOPs, and ensuring regulatory compliance. Her global exposure enhances collaboration, knowledge transfer, and adoption of best practices across diverse research environments.

3. Proficiency in Regulatory and Translational Science

Dr. Boruah has extensive experience in regulatory submissions, preclinical study design, and GLP/GMP compliance, making her adept at navigating the complexities of translational research. She has successfully contributed to FDA, NMPA, and CDSCO submissions, demonstrating her capacity to align innovative research with regulatory and intellectual property standards—a critical skill for turning scientific insights into real-world applications.

4. Strong Scientific Contributions and Impact

With 273 citations, an h-index of 6, and multiple notable publications, Dr. Boruah has established herself as a thought leader in immunology and translational oncology. Her publications cover viral immunopathogenesis, cytokine biology, nanotoxicology, and cancer therapeutics, highlighting her ability to produce high-quality, impactful research. Her review on IL-34 in Critical Reviews in Immunology has become a key reference in the field, underscoring her influence in advancing scientific knowledge.

5. Innovation and Intellectual Property

Dr. Boruah is a co-inventor on two patents filed in India (2024–2025) for an antidiabetic extract and a phytomolecular anti-cancer formulation, demonstrating her drive to translate scientific discoveries into practical therapeutic solutions. Her work exemplifies innovation not just in research methodology but also in developing commercially viable interventions, making her a strong candidate for recognition as an innovative researcher.

Kalpana Nagpal, Pharmacology, Best Innovator Award

Posted on 09/09/2025 by scizentox scizentoxLeave a Comment

Dr. Kalpana Nagpal: Associate Professor & Center Head at Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida (India)

Dr. Kalpana Nagpal is a dedicated Associate Professor at Amity Institute of Pharmacy, Amity University, Uttar Pradesh, with a strong academic background and research expertise in pharmaceutical sciences. She holds a Ph.D. from Guru Jambheshwar University of Science and Technology and has carved a niche in the fields of novel drug delivery systems and pharmaceutical regulatory affairs. Dr. Nagpal combines teaching, innovative research, and mentorship, contributing significantly to the advancement of pharmaceutical education and healthcare technology. She is known for her commitment to fostering research excellence among students and peers alike.

Online Profiles

Google Scholar Profile

Dr. Kalpana Nagpal’s research has garnered significant recognition, with a total of 2,937 citations overall and 1,760 citations since 2020 alone. Her scholarly impact is reflected in an h-index of 23 (20 since 2020) and an i10-index of 34 (27 since 2020), indicating both the productivity and influence of her published work in the pharmaceutical sciences community.

Education

Dr. Nagpal’s academic journey is marked by consistent excellence, having secured gold medals in both her Bachelor’s (B.Pharmacy) and Master’s (M.Pharmacy in Pharmaceutics) degrees from Guru Jambheshwar University of Science and Technology (GJU S&T), Hisar. She further pursued a Ph.D. in Pharmaceutical Sciences at GJU S&T, awarded the prestigious Sir CV Raman Scholarship for her doctoral research completed in 2013. Her educational foundation has enabled her to explore and contribute to complex areas of drug delivery and pharmaceutical regulations with a strong scientific rigor.

Research Focus

Her research primarily revolves around developing novel drug delivery systems that improve therapeutic outcomes and patient compliance. She is especially focused on nanotechnology-based approaches, including lipid-based nanocarriers and brain-targeted delivery systems, aiming to treat neurological and systemic diseases more effectively. Additionally, Dr. Nagpal is deeply involved in pharmaceutical regulatory affairs, studying drug safety, efficacy, and packaging guidelines to ensure compliance with evolving global standards. Her work often integrates in silico studies, in vitro characterization, and in vivo validation to innovate safer, more effective therapies.

Experience

Dr. Nagpal has amassed over 15 years of academic and research experience, having held progressive teaching and research roles. Starting as a Lecturer at Lord Shiva College of Pharmacy, she advanced through Assistant Professor positions at Lovely Professional University and Apeejay Stya University before joining Amity University as an Associate Professor. Her leadership in research supervision has guided numerous M.Pharm and Ph.D. students towards successful completion of their theses. She is known for creating an engaging learning environment, integrating research into teaching, and actively participating in curriculum development and institutional projects.

Research Timeline & Activities

Since 2009, Dr. Nagpal has spearheaded various funded research initiatives in areas such as neuropharmacology, anticancer drug delivery, and pharmaceutical formulation development. She currently holds ongoing projects supported by bodies like the Indian Council of Medical Research (ICMR) and the International Brain Research Organization (IBRO). Her research timeline reflects continuous scholarly productivity, with multiple publications, book chapters, and presentations at international forums. She also organizes workshops and seminars to disseminate knowledge and foster scientific dialogue within the pharmaceutical community.

Awards & Honors

Dr. Nagpal’s exemplary contributions have earned her numerous accolades at the national and international levels. Notably, she received the Haryana Yuva Vigyan Ratan Award for outstanding scientific achievements and was featured among the Top 75 Women Scientists in India by the Principal Scientific Adviser Office’s “She Is Science” initiative. International recognition includes the Young Scientist Award from the Pharmaceutical Royal International Society. Additionally, she has been honored for her innovative teaching methods and research presentations, reflecting her status as a leading figure in pharmaceutical sciences.

Top Noted Publication

Among Dr. Nagpal’s impactful scholarly contributions, the 2012 publication titled “Nanoparticle mediated brain targeted delivery of Gallic Acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity,” published in Drug Delivery (Impact factor 6.819), stands out. This work advanced understanding of brain-targeted drug delivery using nanoparticles, demonstrating significant improvements in therapeutic efficacy and safety profiles in preclinical models. The paper is widely cited and regarded as a key reference in the development of novel neurotherapeutics.

Chitosan nanoparticles: a promising system in novel drug delivery
K. Nagpal, S.K. Singh, D.N. Mishra
Chemical and Pharmaceutical Bulletin, 58(11), 1423-1430 (2010)
Cited by: 849
Niosomes: a controlled and novel drug delivery system
R. Rajera, K. Nagpal, S.K. Singh, D.N. Mishra
Biological and Pharmaceutical Bulletin, 34(7), 945-953 (2011)
Cited by: 486
Supercritical fluid technology: a promising approach in pharmaceutical research
P. Girotra, S.K. Singh, K. Nagpal
Pharmaceutical Development and Technology, 18(1), 22-38 (2013)
Cited by: 215
Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB
K. Nagpal, S.K. Singh, D.N. Mishra
Expert Opinion on Drug Delivery, 10(7), 927-955 (2013)
Cited by: 125
Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety
K. Nagpal, S.K. Singh, D.N. Mishra
International Journal of Biological Macromolecules, 59, 72-83 (2013)
Cited by: 116
Nanomedicine-based delivery strategies for breast cancer treatment and management
P. Tagde, A. Najda, K. Nagpal, G.T. Kulkarni, M. Shah, O. Ullah, S. Balant, …
International Journal of Molecular Sciences, 23(5), 2856 (2022)
Cited by: 105

Strengths for the Best Innovator Award

1. Pioneering Nanotechnology-Based Drug Delivery Systems

Dr. Kalpana Nagpal has emerged as a leading innovator in nanotechnology-driven drug delivery, focusing on the development of novel nanoscale carriers that enhance targeted therapy, particularly for neurological disorders. Her groundbreaking research on brain-targeted nanoparticles has addressed one of the most challenging barriers in pharmaceutical science — the blood-brain barrier — thereby enabling improved therapeutic efficacy and safety. This work not only advances fundamental science but also paves the way for translational applications in treating neurodegenerative and psychiatric diseases.

2. Integration of Pharmaceutical Regulatory Affairs with Drug Development

Innovating beyond the lab bench, Dr. Nagpal uniquely bridges the gap between drug development and regulatory compliance. She has extensively contributed to pharmaceutical regulatory affairs by developing guidelines for drug safety, packaging, and quality standards, ensuring that novel drug delivery systems meet global regulatory requirements. This dual expertise accelerates the translation of innovative formulations from research to market, enhancing patient access to safe and effective medications.

3. Outstanding Research Leadership and Mentorship

With over 15 years of academic and research experience, Dr. Nagpal has demonstrated exemplary leadership in mentoring the next generation of pharmaceutical scientists. She has successfully supervised more than 20 postgraduate and doctoral students, guiding them to award-winning theses and fostering a research culture that encourages innovation and scientific rigor. Her ability to manage multidisciplinary research projects funded by prestigious agencies like ICMR and IBRO showcases her capability as an effective leader and innovator.

4. Multidisciplinary and Translational Research Approach

Dr. Nagpal adopts a comprehensive, multidisciplinary approach that integrates computational (in silico) modeling, laboratory-based (in vitro) experiments, and animal model (in vivo) validations. This full-spectrum methodology accelerates the design, optimization, and clinical relevance of novel pharmaceutical formulations. Her translational focus ensures that innovations are not only scientifically sound but also clinically applicable, directly impacting patient care and treatment outcomes.

5. Internationally Recognized Scholarly Impact

Dr. Nagpal’s research has garnered over 2,900 citations globally, with an h-index of 23 and an i10-index of 34, reflecting the high impact and relevance of her work in pharmaceutical sciences. Her widely cited publications, including seminal papers on chitosan nanoparticles and brain-targeted delivery, underscore her contribution to the field. Recognition from international bodies and collaborations further attest to her role as a global innovator driving advances in drug delivery technologies.

Shruti Patel, Pharmacology, Best Innovator Award

Posted on 05/09/2025 by scizentox scizentoxLeave a Comment

Dr. Shruti Patel: Assistant professor at Parul Institute of Pharmacy, Parul University, India

Title/Designation: Dr.
Name: Shruti Patel
Current Role/Designation: Assistant Professor
Organization/Institution: Parul Institute of Pharmacy, Parul University
Country: India
Subject Track: Pharmacology
Award Categories: Best Innovator Award

Dr. Shruti Jagdishbhai Patel is a highly motivated and accomplished academician and researcher in the field of pharmaceutical sciences, with a specialization in nanotechnology-based drug delivery systems. She currently serves as an Assistant Professor in the Department of Pharmaceutics at Parul Institute of Pharmacy, Parul University, Vadodara, India. With over seven years of academic and research experience, she has demonstrated excellence in teaching, research, and innovation. Her core research interests lie in the development of novel polymeric and lipid-based nanocarriers for the targeted delivery of therapeutic agents, particularly in oncology and inflammatory diseases. Through her work, she strives to bridge the gap between laboratory research and clinical application, and has made significant contributions through her publications, patents, funded projects, and mentorship. Dr. Patel has also been recognized for her academic achievements, including receiving the Best Ph.D. Thesis Award and the Best Research Performance Award in 2024.

Online Profiles

Google Scholar Profile

Dr. Shruti Patel has a steadily growing academic impact, as evidenced by her Google Scholar metrics. She has accumulated a total of 169 citations, with 112 citations since 2020, reflecting the relevance and ongoing influence of her work in recent years. Her h-index is 7, indicating that at least seven of her publications have been cited seven or more times, and her i10-index is 4, with three of those articles published since 2020 receiving at least ten citations each. These metrics highlight her meaningful contribution to pharmaceutical nanotechnology and underscore the scholarly value of her research in drug delivery and formulation sciences.

Education

Dr. Patel’s academic journey reflects a consistent trajectory of excellence and specialization in pharmaceutics. She earned her Ph.D. in 2023 from Parul University, with a thesis focused on the “Development of Novel Colloidal Drug Delivery Systems Using a Quality by Design (QbD) Approach,” under the mentorship of Dr. Asha Patel. Her research was recognized as the Best Ph.D. Thesis by Parul University, acknowledging both the scientific merit and practical applicability of her work. Prior to her doctorate, she obtained her M.Pharm in Pharmaceutics in 2016 from Gujarat Technological University with a distinction grade, demonstrating a strong understanding of formulation science and advanced drug delivery systems. She began her academic foundation with a B.Pharm degree from the same university in 2014, graduating with an impressive 8.17 CGPA. Her formal education has been instrumental in building a solid foundation in formulation science, nanotechnology, pharmacokinetics, and QbD methodologies.

Research Focus

Dr. Patel’s research expertise centers around the design and development of advanced nanocarrier systems for site-specific and sustained drug delivery. Her work includes the formulation of functionalized nanomicelles, self-assembled protein nanoparticles, liposomes, and polymeric nanocarriers for the treatment of diseases like lung cancer, breast cancer, Alzheimer’s, psoriasis, and ocular disorders. A distinctive aspect of her research is the incorporation of Quality by Design (QbD) and chemometric tools for optimization and predictive modeling of drug formulations. She also explores surface modification techniques such as ligand conjugation (e.g., folate, lactoferrin, avidin-biotin) to enhance targeting and therapeutic outcomes. Her interdisciplinary approach integrates pharmaceutical sciences, biomedical engineering, and material sciences, and reflects a commitment to innovation in drug delivery and personalized medicine.

Experience

Dr. Patel has accumulated nearly eight years of academic and research experience at Parul University, where she has contributed extensively as an Assistant Professor in the Department of Pharmaceutics since July 2017. In her role, she teaches core subjects related to pharmaceutics, nanotechnology, and advanced drug delivery systems at both undergraduate and postgraduate levels. She has been instrumental in establishing a research culture within her department, actively engaging in curriculum development, laboratory coordination, and academic audits. Beyond classroom teaching, she has supervised several postgraduate dissertations and is currently guiding a Ph.D. scholar working on lipid nanocarriers for colorectal cancer therapy. Her contributions also extend to research proposal writing, handling of funded projects, peer-reviewing journal manuscripts, and participating in scientific committees. She is known for her strong work ethic, leadership in research execution, and mentorship qualities.

Research Timeline & Activities

Dr. Patel’s research timeline showcases a steady and impactful progression from postgraduate research to becoming a principal investigator in funded projects. During her Ph.D., she worked on a prestigious AICTE-RPS funded project focusing on block co-polymeric micelles for lung cancer therapy. She successfully transformed this work into multiple peer-reviewed publications, a national patent, and a prestigious thesis award. Following her doctoral work, she expanded her research into protein nanocarriers, surface-functionalized liposomes, and chemometric modeling. Between 2018 and 2024, she supervised over seven postgraduate students on cutting-edge topics including CAR-M therapy for Alzheimer’s, dry powder inhalers for lung disease, and lipid-based ophthalmic formulations. She has authored 19 research papers with a cumulative impact factor of 35.66 and has applied for 9 patents (1 granted). She also led and contributed to grant proposals for GSBTM and DST, securing significant research funding, and has become a recognized figure in pharmaceutical nanotechnology research.

Awards & Honors

Dr. Shruti Patel has received significant recognition for her scientific and academic contributions. In 2024, she was honored with the Best Ph.D. Thesis Award by Parul University, a distinction that reflects the novelty, execution, and impact of her doctoral research. In the same year, she received the Best Overall Research Performance Award from the university, acknowledging her consistent research output, patent filings, project leadership, and scholarly publications. Her research proposal on antibody-targeted nanotheranostics was awarded a major grant by the Gujarat State Biotechnology Mission (GSBTM), demonstrating her ability to conceptualize and lead high-value research initiatives. Her accolades reflect both individual excellence and her contribution to the broader scientific community.

Top Noted Publication

Among her 19 research articles, one of Dr. Patel’s most cited and widely recognized papers is “Development of surface-conjugated block co-polymeric micelles as targeted therapeutics: characterization and in-vitro cell viability,” published in the Journal of Polymer Research (Springer, Impact Factor: 3.061). This work highlighted the design of micelle-based nanocarriers for targeted cancer treatment and provided in-depth in vitro analysis, making it a significant contribution to the field. Another landmark publication is her collaborative work on avidin-biotin functionalized nanoparticles for EGFR-targeted lung cancer therapy, published in Journal of Dispersion Science and Technology. She has also co-authored high-impact reviews in Journal of Drug Targeting (IF: 4.3) and Current Drug Targets (IF: 3.5), which reflect her diverse capabilities in both experimental and theoretical domains. These publications collectively strengthen her position as a leading researcher in advanced drug delivery systems.

“Religions and international poverty alleviation: The pluses and minuses”, co-authored with JP Martin and J Chau, was published in the Journal of International Affairs and has received 36 citations since 2007. This article explores the role of religious institutions in global poverty initiatives and remains relevant in development studies.
Her recent nanotechnology-focused paper, “Zeolite-based nanoparticles drug delivery systems in modern pharmaceutical research and environmental remediation”, published in Heliyon (2024), has already gathered 19 citations, reflecting rapid academic uptake in pharmaceutical sciences and environmental health.
In the field of religious studies, her solo-authored work titled “Beyond the lens of reform: Religious culture in modern Gujarat”, published in The Journal of Hindu Studies, has attracted 14 citations and contributes significantly to understanding the interplay between religious tradition and modernity in Indian society.
The article “Road use pattern and street crossing habits of schoolchildren in India”, published in Frontiers in Public Health in 2021, has received 10 citations, demonstrating her engagement with public health and child safety.
Another noteworthy contribution includes her co-authored paper “Bio-functional mesoporous silica nanoparticles as nano-structured carriers in cancer theranostic review”, published in Current Drug Targets (2023), which has already accumulated 8 citations, emphasizing her impactful work in cancer nanomedicine.

Swati Pandey, Pharmacology, Outstanding Researcher Award

Posted on 31/08/2025 by scizentox scizentoxLeave a Comment

Dr. Swati Pandey: Associate Professor at SAGE University Bhopal, India

Dr. Swati Pandey is a seasoned academic and researcher specializing in Pharmaceutical Chemistry with a robust background in analytical chemistry, drug development, and formulation science. With more than a decade of experience in teaching and research, she is currently an Associate Professor at SAGE University, Bhopal. Dr. Pandey has earned recognition for her work in impurity profiling, stability-indicating methods, and quality-by-design approaches in drug formulation. Her research is known for its innovative techniques in pharmaceutical analysis and drug characterization, which has contributed to advancing both academic knowledge and practical pharmaceutical applications.

Online Profiles

Scopus Profile

Citations: 42 citations across 42 documents
h-index: 3
Published Documents: 10

Dr. Pandey maintains an active and professional presence on various online academic platforms such as LinkedIn, ResearchGate, and Google Scholar, where she shares her latest research findings, papers, and academic contributions. Her profiles showcase her collaboration with fellow researchers, her involvement in cutting-edge pharmaceutical research, and her role as a thought leader in her field. Through these platforms, Dr. Pandey engages with the global scientific community, promoting dialogue on emerging trends in pharmaceutical chemistry and education.

Education

Dr. Pandey’s educational journey is characterized by excellence and a deep commitment to the pharmaceutical sciences. She earned her M. Pharm. in Pharmaceutical Chemistry, where she was recognized as a Gold Medalist, from Chhattisgarh Swami Vivekanand Technical University. This was followed by her B. Pharm. from Guru Ghasidas Central University, where she also secured top honors. Her academic journey culminated in the award of a Ph.D. in Pharmacy in 2023, marking the peak of her research career. Dr. Pandey’s academic rigor and commitment to excellence are at the core of her research methodology and her approach to pharmaceutical education.

Research Focus

Dr. Pandey’s research focus spans a diverse range of topics within pharmaceutical chemistry, with particular emphasis on analytical method development and the characterization of drug formulations. Her studies often center on stability-indicating methods, impurity profiling, and bioanalytical techniques such as HPLC, UV spectrophotometry, and FT-IR. She is also exploring the innovative use of phytosomes for delivering herbal drugs and their potential immunodulatory effects. Furthermore, Dr. Pandey has a strong interest in Quality by Design (QbD) principles, particularly in their application for developing robust, reproducible, and regulatory-compliant pharmaceutical products.

Experience

With over 11 years of experience, Dr. Pandey has held various roles in both academic and research domains. She has served as an Assistant Professor and Associate Professor in reputed institutions such as the Columbia Institute of Pharmacy and Sagar Institute of Research & Technology-Pharmacy. Her experience includes not just teaching, but also mentoring students, conducting industry-driven research, and designing innovative curriculum to ensure that her students gain practical, industry-relevant skills. Dr. Pandey’s rich blend of experience in both industry and academia gives her a unique perspective on the real-world applications of pharmaceutical sciences.

Research Timeline & Activities

Dr. Pandey’s research career is marked by significant contributions to the field of pharmaceutical analysis. Her early work focused on the application of chromatographic techniques in drug analysis, while more recent research has incorporated the use of advanced analytical instruments to understand drug stability and impurities. Over the years, Dr. Pandey has presented her work at numerous international conferences and seminars, where she has shared her research on topics ranging from the validation of pharmaceutical assays to the role of phytosomal formulations in drug delivery systems. In addition to publishing in peer-reviewed journals, she also actively participates in workshops, aiming to enhance her skills and collaborate with fellow researchers on the latest trends in pharmaceutical sciences.

Awards & Honors

Throughout her academic career, Dr. Pandey has been honored with numerous awards recognizing her scholarly excellence and research achievements. Notably, she received a Gold Medal for both her B. Pharm. and M. Pharm. degrees, cementing her place among the top performers in her field. Additionally, she has been awarded the “Best Oral Presentation Award” at national and international conferences. Dr. Pandey has also been recognized as the “Best Employee of the Year” at Columbia Institute of Pharmacy for her dedication to teaching and research. These accolades reflect her deep commitment to advancing pharmaceutical sciences through innovation, mentorship, and rigorous academic work.

Top Noted Publication

Dr. Pandey has contributed to a number of high-impact publications in leading journals within the pharmaceutical sciences domain. Her most noted publications include her work on “Qb-D Driven Development & Validation of RP-HPLC Method for the Estimation of Nevirapine,” which was published in Chromatographia, an SCI-indexed journal. In addition, her publication titled “Fourier Transform Infrared Spectroscopy: Recent Advances in Analytical Method Development” in the Research Journal of Pharmacy & Technology has garnered significant attention for its in-depth analysis of analytical techniques and their evolving role in pharmaceutical research. These publications not only highlight Dr. Pandey’s technical expertise but also her commitment to advancing research in pharmaceutical chemistry and drug development.

Validated Stability-indicating Method Development Designed for the Determination of Metronidazole in the Presence of Povidone-Iodine in Dermatological Formulation by First-Order Derivative UV Spectrophotometric Method
Published in: Journal of Applied Spectroscopy, Vol. 92, No. 2, May 2025
Publisher: Springer Nature
Indexing: Scopus Indexed
Focus: This paper presents a stability-indicating UV spectrophotometric method for the quantification of metronidazole in dermatological formulations, with the presence of povidone-iodine. It offers a valuable contribution to pharmaceutical analysis by addressing method validation.
Fourier Transform Infrared Spectroscopy: Recent Advances and Prospective in Analytical Method Development and Validation
Published in: Research Journal of Pharmacy & Technology, 17(6), June 2024
Indexing: Scopus Indexed
Focus: This review explores the recent advancements in Fourier Transform Infrared (FTIR) Spectroscopy, a powerful analytical technique. It discusses its applications in method development and validation, providing an updated perspective on FTIR’s role in pharmaceutical research.
Bisoprolol Fumarate: An Exploration on Its Properties and Analytical Methods
Published in: Palestinian Medical & Pharmaceutical Journal, Vol. 9, Issue 4, Article 6
DOI: https://doi.org/10.59049/2790-0231.1272
Indexing: ScienceDirect; Scopus Indexed
Focus: This article delves into the chemical properties of Bisoprolol Fumarate, a widely used beta-blocker, and reviews various analytical methods for its quantification. The paper aims to enhance the understanding of the drug’s characterization in pharmaceutical research.
Sensitive and Rapid Estimation of Isoniazid in Bulk and Solid Dosage Form by Reverse Phase Liquid Chromatography
Published in: Journal of Basic Science, 2024, Vol 24, Issue 1, Pg. 230-243
Indexing: Scopus Indexed
Focus: The study focuses on developing a rapid and sensitive reverse-phase liquid chromatography (RPLC) method for the estimation of Isoniazid in both bulk and solid dosage forms, providing a crucial analytical tool for tuberculosis therapy monitoring.

Dr. Swati Pandey strength for the Outstanding Researcher Award:

1. Innovative Analytical Techniques

Dr. Pandey has made significant contributions to pharmaceutical analysis, particularly in the development of stability-indicating methods and impurity profiling. Her research incorporates advanced techniques like HPLC, UV spectrophotometry, and FT-IR spectroscopy, ensuring that her work stays on the cutting edge of the field. Her innovation in analytical methods, including the development of a UV spectrophotometric method for metronidazole in dermatological formulations, showcases her capacity to solve complex pharmaceutical problems.

2. Impactful Research Contributions

Her work on “Qb-D Driven Development & Validation of RP-HPLC Method for the Estimation of Nevirapine” published in Chromatographia is a key example of her impactful contributions. She continues to publish in high-impact, Scopus-indexed journals, ensuring her research reaches a global audience and is applied in both academic and industrial settings. This solid publication record reflects her ongoing commitment to advancing the field of pharmaceutical chemistry.

3. Multidisciplinary Expertise

Dr. Pandey brings together expertise from various disciplines, including pharmaceutical chemistry, drug development, and formulation science. Her research extends to the development of phytosomal formulations for herbal drugs, bridging the gap between traditional and modern drug delivery systems. This broad approach positions her as a versatile researcher capable of working on cutting-edge interdisciplinary topics in the pharmaceutical sciences.

4. Global Collaboration and Academic Engagement

Active participation in international conferences and seminars, as well as engagement on academic platforms like ResearchGate and Google Scholar, enhances Dr. Pandey’s visibility in the global scientific community. Her collaborations with researchers worldwide and her dedication to advancing academic knowledge contribute to a thriving international research network, promoting the exchange of innovative ideas and approaches.

5. Mentorship and Education Excellence

Beyond her research, Dr. Pandey has demonstrated exceptional skills in mentoring students and shaping future researchers. As an Associate Professor at SAGE University Bhopal, she has contributed to the development of the next generation of pharmaceutical scientists by designing industry-relevant curricula and guiding students in research. Her focus on both theoretical and practical knowledge ensures that her students are well-prepared for the challenges in pharmaceutical sciences.

Sourav Pal, Pharmacology, Best Innovator Award

Posted on 19/08/2025 by scizentox scizentoxLeave a Comment

Asst. Prof. Sourav Pal: Assistant Professor at Department of Pharmacology, Seacom Pharmacy College, Jaladhulagori, Sankrail, Howrah, West Bengal, 711302, India

Sourav Pal is a dedicated academic and researcher in the field of Pharmaceutical Sciences with a focus on Pharmacology. He currently serves as an Assistant Professor at Seacom Pharmacy College, Howrah, since July 2024, where he actively contributes to teaching, research, and curriculum development. Sourav’s academic journey culminated in a Master’s in Pharmacy (Pharmacology) from Calcutta Institute of Pharmaceutical Technology & Allied Health Sciences in 2022, achieving a commendable CGPA of 9.58. His research is centered on exploring the pharmacological and therapeutic potential of plant-based compounds, as well as assessing the neurobehavioral and toxicological effects of various substances. He is also passionate about the integration of artificial intelligence (AI) and machine learning in pharmaceutical research, particularly in drug design and delivery systems.

Online Profiles

ORCID Profile

Education

Sourav Pal’s academic foundation is rooted in his profound interest in the pharmaceutical sciences. He earned his Master’s in Pharmacy (Pharmacology) from Calcutta Institute of Pharmaceutical Technology & Allied Health Sciences in 2022, where he stood out with a CGPA of 9.58. Prior to that, he completed his Bachelor’s in Pharmacy with an outstanding CGPA of 8.90 in 2020. His academic pursuits began with his Higher Secondary education in 2016 at Bangalpur U.C High School, achieving 73%, followed by his Secondary Education in 2014, where he scored 76.5%. Throughout his academic career, Sourav has remained dedicated to enhancing his knowledge in both theoretical and practical aspects of pharmacology.

Research Focus

Sourav’s research primarily investigates the pharmacological properties of medicinal plants and synthetic compounds, emphasizing their neuroprotective, antioxidant, and antimicrobial activities. His recent studies focus on the toxicological effects of plant extracts, such as Swietenia mahagoni and Mimosa pudica, on animal models, exploring their potential to treat neurological diseases, including Alzheimer’s and Parkinson’s. He is particularly interested in the molecular mechanisms underlying neurodegeneration and the role of heavy metals and oxidative stress in the progression of neurological diseases. Sourav also explores advanced drug delivery systems, particularly those involving nanoformulations, to improve the efficacy and safety profiles of pharmaceutical compounds.

Experience

Sourav’s career has spanned both teaching and research, with a focus on integrating advanced pharmacological concepts into practical learning experiences. As an Assistant Professor at Seacom Pharmacy College, Howrah, he actively engages in curriculum development, student mentoring, and research supervision. Before this, he worked as a Lecturer/Assistant Professor at P.G. Institute of Medical Sciences, Chandrakona Town, where he contributed significantly to the academic growth of students and led research projects on pharmacological evaluations of herbal extracts. Sourav has built a reputation for his problem-solving skills, innovative approach to teaching, and his ability to identify and nurture the strengths of his students.

Research Timeline & Activities

Sourav’s research timeline includes multiple projects that span various aspects of pharmacology and toxicology. His earlier projects, including his work on Sechium edule (chayote), involved assessing the antihyperlipidemic effects and exploring its potential to mitigate cardiovascular conditions. More recently, he has supervised research on the antioxidant and neuroprotective effects of Swietenia mahagoni in zebrafish models. Sourav has mentored several graduate students, guiding them through experimental methodologies, data analysis, and scientific writing. Additionally, he actively participates in international and national conferences, webinars, and faculty development programs (FDPs), particularly those focusing on AI, machine learning, and advanced research methodologies.

Awards & Honors

Life Membership in the Association of Pharmaceutical Teachers of India (APTI) (ID: WB/LM-367, 2023)
Reviewer for prestigious international journals such as Molecular Neurobiology, Biochemical Genetics, and The Journal of Basic and Applied Zoology.
Registered Pharmacist (A-24986) with the West Bengal Pharmacy Council
Best Research Paper Award at various national and international conferences on drug discovery and pharmacology.
Recognized for contributions to pharmaceutical education and research through awards from academic institutions and research organizations.

Top Noted Publication

Sourav has published over 15 research papers, covering a wide range of topics in pharmacology, toxicology, and plant-based therapeutics. Notable among them are:

1. Antioxidants in Cardiovascular Disease: Molecular Interaction and Therapeutic Implications

Book Chapter: Antioxidants: Nature’s Defense Against Disease
Publication Year: 2025
DOI: 10.1002/9781394270576.ch4
ISBN: 9781394270576, 9781394270552
Contributors: Firdous, S.M.; Pal, S.
Source: Scopus – Elsevier
Summary: This chapter delves into the molecular interactions of antioxidants within the cardiovascular system, emphasizing their therapeutic potential in combating cardiovascular diseases (CVD). It explores the role of oxidative stress in the pathogenesis of CVD and the protective actions of antioxidants at a molecular level, presenting new therapeutic strategies for CVD management.

2. Antioxidants in Inflammatory Diseases

Book Chapter: Antioxidants: Nature’s Defense Against Disease
Publication Year: 2025
DOI: 10.1002/9781394270576.ch3
ISBN: 9781394270576, 9781394270552
Contributors: Firdous, S.M.; Pal, S.; Mandal, S.; Sindhu, R.K.
Source: Scopus – Elsevier
Summary: This chapter investigates the role of antioxidants in the prevention and treatment of inflammatory diseases. The text covers molecular mechanisms by which antioxidants mitigate inflammatory responses and discusses their clinical application in inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and other chronic inflammatory disorders.

3. Neurobehavioral Effects and Brain GFAP Modulation by Mimosa pudica Extract in Zebrafish Exposed to Zinc Oxide Nanoparticles

Journal Article: The Journal of Basic and Applied Zoology
Publication Date: 17th August 2025
DOI: 10.1186/s41936-025-00484-z
Contributors: Sourav Pal; Brisanka Tarafder; Debashish Dey; Sayed Mohammed Firdous
Source: Crossref
Summary: This study assesses the neurobehavioral effects of Mimosa pudica extract in zebrafish exposed to zinc oxide nanoparticles. The research focuses on the modulation of brain glial fibrillary acidic protein (GFAP), which serves as a marker for neuroinflammation. The findings support the neuroprotective potential of Mimosa pudica against neurotoxicity induced by nanoparticles, offering insights into natural products for neurological protection.

4. Helicobacter pylori in Peptic Ulcer Disease: Pathogenesis, Gastric Microbiome, and Innovative Therapies

Journal Article: Bulletin of the National Research Centre
Publication Date: 12th August 2025
DOI: 10.1186/s42269-025-01346-y
Contributors: Sourav Pal; Junaid Ahamed Laskar; Biprojit Bhowmick; Khokan Bera
Source: Crossref
Summary: This article explores the role of Helicobacter pylori in the pathogenesis of peptic ulcer disease and its impact on the gastric microbiome. It provides a comprehensive review of current therapeutic strategies and discusses innovative approaches, such as targeted microbiome manipulation and novel anti-H. pylori treatments, offering new directions for peptic ulcer management.

5. Therapeutic Potential of MicroRNAs in Neurological Disorders: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies

Journal Article: Exploration of Neuroprotective Therapy
Publication Date: 14th July 2025
DOI: 10.37349/ent.2025.1004111
Contributors: Sourav Pal; Subhajit Mandal
Source: Crossref
Summary: This article examines the potential of microRNAs as biomarkers and therapeutic agents in neurological disorders. It explores the molecular mechanisms underlying microRNA regulation in the brain and their involvement in neurodegenerative diseases. The review also discusses the emerging therapeutic strategies that target microRNAs for neuroprotection, providing insight into the future of personalized treatment for neurological diseases.